Sector portfolio · VC firm · United States
Burrill & Company's Biotech portfolio
Burrill & Company has backed 10 Biotech startups in rounds we track, $246M between them, shown by the stage each has reached. The best-funded is Nucleonics.
Funding by segment
- Series B$109M4
- Series A$103M4
- Stage not reported$34M2
Where they are based
- United States10$246M
United StatesFounded
Total raised
- Under $1M0
- $1M to $10M3
- $10M to $50M7
- $50M to $250M0
- $250M to $1B0
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
9 of 10 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States10
Startups by country, 1 country in all.
Segment by segment
Series B
4 startups · $109M raised
- NNucleonicsNucleonics is a biotechnology company focused on RNA interference-based therapeutics.United States$49M
- FBFerroKin BiosciencesFerrokin Biosciences develops and markets medical devices such as Iron Chelator for the treatment of iron-overload in patients.United States$30M
- NTNora TherapeuticsNora develops therapeutics to address unmet clinical needs in reproductive medicine.United States$21M
- SGSpectral GenomicsSpectral Genomics, a pioneer in technology for the genome with headquarters in Houston, TX, is a global supplier of innovative products.United States$9.3M
Series A
4 startups · $103M raised
- CCardiokineCardiokine, Inc., a specialty pharmaceutical company, engages in the development of pharmaceuticals for the prevention and treatmeUnited States$37M
- ATArete TherapeuticsArete Therapeutics is a pharmaceutical company that develops small molecule therapeutics for diabetes and cardiovascular disease.United States$35M
- OPOsprey Pharmaceuticals USAOsprey Pharmaceuticals USA develops novel protein therapeutics for the treatment of inflammatory and immune diseases.United States$23M
EfficasEfficas is a health-science and technology company.United States$7.9M
Stage not reported
2 startups · $34M raised
ProteoGenixProteoGenix is a leading life sciences organization which provides services in molecular biology and immunology and in particular United States$28M
Emerald BioAgriculture CorporationEmerald BioAgriculture Corporation is a privately held company that develops biochemical products to increase crop production.United States$6.2M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Burrill & Company as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Burrill & Company?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.